Agennix AG

Agennix AG
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
EUR2.05 M
Shares Outstanding
51.27 M
Public Float
-

Profile

Address
Im Neuenheimer Feld 515
Heidelberg Baden Wuerttemberg 69120
Germany
Employees -
Website http://www.agennix.com
Updated 09/14/2018
Agennix AG is a biopharmaceutical company, which engages in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs include oral talactoferrin alfa and RGB-286638. The company was founded on November 5, 2009 and is headquartered in Heidelberg, Germany.

Financials

View All
Created with Highcharts 5.0.14Agennix AGNet Income. Fiscal year is January-December. All values EUR Thousands.21 28421 28411 93811 93827 00227 00241 82641 8262008200920102011010k20k30k40k50k
Created with Highcharts 5.0.14Agennix AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.12 37212 3727 7467 74615315300200820092010201102.5k5k7.5k10k12.5k15k

Christof Hettich
Chairman-Supervisory Board
James D. Weaver
Member-Supervisory Board